Home » Estrogen Receptor Mutations in cfDNA Linked to Shorter Metastatic Breast Cancer Survival

Estrogen Receptor Mutations in cfDNA Linked to Shorter Metastatic Breast Cancer Survival

Aug 11, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Mutations in the estrogen receptor gene ESR1 appear to be linked to more aggressive disease and poorer patient outcomes in individuals with estrogen receptor-positive metastatic breast cancer, according to a study published today in JAMA Oncology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

What's Popular?

In Molecular Diagnostics

  1. ASCO Updates NSCLC Guidelines With New Directives for Genomic Testing

  2. Dutch Researchers Develop ThromboSeq Test to Detect Lung Cancer

  3. Innovate UK Awards Atlas Genetics £2M Grant for Rapid Diagnostic Platform

  4. FDA Clears iCubate System, Bloodstream Infection Assay

  5. Biofortuna to Further Commercialize Genotyping Assays With £1.6M Financing

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.